Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Mark Niebauer, MD is a staff cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing at the Cleveland Clinic. Dr. Niebauer has a special interest in cardiac defibrillation, cardioversion and catheter cryoablation. He currently sees patients with ventricular and supraventricular tachycardia, including atrial fibrillation and flutter as well as Wolff-Parkinson-White syndrome.
Dr. Niebauer earned a BS in Chemistry from Ball State University, Muncie, Ind., and a Master's in Biology followed by a PhD in Physiology from Purdue University. His PhD research was on cardiac defibrillation. After receiving his PhD, he was a research fellow with the American Heart Association and the National Institutes of Health at the University of Nebraska before entering medical school at Creighton University, Omaha.
Dr. Niebauer received his medical degree in 1988 and went on to serve his residency in internal medicine at the University of Michigan followed by fellowships in cardiovascular medicine and cardiac electrophysiology at that institution. He originally joined the Cleveland Clinic staff in 1995 and left the Clinic in 2002 for the University of Nebraska Medical Center where he was Director of Cardiac Electrophysiology and an Associate Professor of Medicine from 2002-2008. He returned to the Cleveland Clinic in 2008.
A fellow of the American College of Cardiology since 1997, Dr. Niebauer is also a fellow of the Heart Rhythm Society, a member of the Cardiac Electrophysiology Society and the American Heart Association Clinical Cardiology Scientific Council. In addition, he serves as a data safety board member for Ablation Frontiers, Inc.
Dr. Niebauer is board-certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology. He has authored over one hundred papers and abstracts in leading scientific journals and speaks at national and international conferences related to cardiac electrophysiology and defibrillation.
Abnormal Heart Rhythms, Long QT Syndrome, Atrial Fibrillation, Supraventricular Tachycardia, Ventricular Tachycardia, Biventricular Pacemaker, Catheter Ablation, Lead Extraction, Implantable Cardioverter Defibrillator, Pacemaker Implant, Pulmonary Vein Isolation Ablation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/8/2013, Dr. Niebauer has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.